FDA Guidance for Industry: M4E(R2): The CTD – Efficacy ICH Harmonised Guideline Revision of M4E Guideline on enhancing the format and structure of benefit-risk information in ICH Posted on the FDA website on 1 October 2015 editor2015-10-05T23:12:20+00:0006.10.2015|Regulatory Affairs, Training| Comparta esta información, escoja su plataforma FacebookTwitterLinkedInEmail